Real-time enrollment status for this hematologic malignancies clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:22 PM UTC
| NCT Number | NCT05322850 |
| Recruiting Status | Recruiting |
| Condition | Hematologic Malignancies |
| Phase | PHASE1 |
| Target Enrollment | 40 participants |
| Active Locations | 4 sites in the US |
| Sponsor | University of Florida |
| Last Updated on CT.gov | September 1, 2026 (Sep 1, 2026) |
As of October 12, 2026: Clinical trial NCT05322850 is currently recruiting participants. This phase1 study for hematologic malignancies is actively seeking new participants at 4 locations across the United States. The study is sponsored by University of Florida. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05322850 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05322850 was last updated Sep 1, 2026 (September 1, 2026). HelloStudys verifies this status automatically.